StockComparison Logo
vs

BN vs GSK

Comparison between Brookfield Corporation - Class A (BN, Company) and GSK Plc (GSK, Company).

BN is from the Financial Services sector, while GSK is from the Healthcare sector.

5-Year PerformanceBN has outperformed GSK, delivering a return of +10.1% compared to +4.8%

BN vs GSK - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
BN
$105B
GSK
$103B
Max Drawdown
BN
73.40%
Winner
GSK
64.03%
Sharpe Ratio
BN
0.43
Winner
GSK
1.30
5Y Beta
BN
1.45
Winner
GSK
0.23
Industry
BN
Asset Management
GSK
Drug Manufacturers - General
P/E Ratio
BN
78.72
Winner
GSK
11.92
Forward P/E
Winner
BN
11.89
GSK
21.23
PEG Ratio
BN
0.67
Winner
GSK
0.10
Dividend Yield
BN
0.56%
Winner
GSK
3.55%
5Y Dividends CAGR
BN
-9.86%
Winner
GSK
1.34%
5Y EPS CAGR
BN
-1.09%
Winner
GSK
4.65%
Debt to Equity
BN
571.67%
Winner
GSK
106.74%
Free Cash Flow Yield
BN
-7.86%
Winner
GSK
8.15%
P/S Ratio
Winner
BN
1.25
GSK
3.10
P/B Ratio
Winner
BN
2.55
GSK
4.24

BN vs GSK - Historical Returns

Returns include dividend reinvestment.

1M
BN
-5.23%
Winner
GSK
-0.54%
3M
Winner
BN
+9.63%
GSK
-2.72%
6M
BN
-7.59%
Winner
GSK
+6.07%
1Y
BN
+5.64%
Winner
GSK
+36.91%
5Y(CAGR)
Winner
BN
+10.08%
GSK
+4.80%
10Y(CAGR)
Winner
BN
+15.14%
GSK
+4.78%
Max(CAGR)
Winner
BN
+18.27%
GSK
+3.09%

BN vs GSK - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearBNGSK
2026-7.63%+4.63%
2025+20.33%+50.62%
2024+48.89%-6.27%
2023+28.19%+9.25%
2022-34.35%-32.73%
2021+56.21%+23.62%
2020+8.87%-17.52%
2019+54.24%+30.36%
2018-9.63%+9.29%
2017+33.02%-3.80%
2016+10.47%+1.52%
2015-4.72%+0.48%
2014+31.81%-14.73%
2013+9.81%+26.97%
2012+33.58%-0.75%
2011-16.44%+22.51%
2010+52.46%-3.72%
2009+48.15%+20.27%
2008-55.15%-21.93%
2007+14.67%-2.77%
2006+42.45%+6.93%
2005+43.00%+9.96%
2004+77.08%+5.08%
2003+56.79%+25.04%
2002+22.19%-22.83%
2001+34.46%-9.58%
2000+13.72%+5.67%
1999+3.38%-5.78%

BN vs GSK Drawdown Comparison

The maximum drawdown for BN was -71.78%, occurring on Mar 9, 2009. Recovery took 1438 trading sessions.

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The current BN drawdown is -12.40%. The current GSK drawdown is -15.12%.

RankBNGSK
#1-71.78%
May 22, 2007 - Feb 6, 2013
-50.11%
Apr 13, 2022 - Jan 6, 2026
#2-51.42%
Feb 20, 2020 - Mar 17, 2021
-49.64%
Apr 20, 2007 - Apr 18, 2012
#3-41.86%
Oct 28, 2021 - Jul 31, 2024
-45.23%
Apr 25, 2000 - Nov 11, 2005
#4-28.63%
Apr 15, 2015 - May 2, 2017
-32.56%
Jan 17, 2020 - Dec 10, 2021
#5-27.85%
Jan 30, 2025 - Jun 30, 2025
-27.97%
Mar 4, 2014 - Sep 3, 2019
#6-22.05%
Jan 6, 2026 - Mar 20, 2026
-26.98%
Nov 5, 1999 - Apr 11, 2000
#7-21.46%
Jun 7, 2002 - May 6, 2003
-18.61%
Feb 18, 2026 - Jun 2, 2026
#8-20.13%
Jan 10, 2000 - Aug 24, 2000
-14.45%
Jan 18, 2022 - Apr 7, 2022
#9-19.03%
Aug 23, 2001 - Dec 27, 2001
-10.52%
May 16, 2006 - Feb 13, 2007
#10-18.08%
Oct 1, 2018 - Feb 26, 2019
-10.48%
Oct 4, 2012 - Mar 22, 2013
#11-17.84%
Mar 30, 2004 - Jun 8, 2004
-8.45%
May 28, 2013 - Nov 1, 2013
#12-15.94%
Nov 23, 2004 - Aug 25, 2005
-8.43%
Apr 11, 2000 - Apr 25, 2000
#13-13.79%
Aug 25, 2000 - Nov 15, 2000
-8.16%
Nov 11, 2005 - Mar 8, 2006
#14-13.63%
Dec 13, 2017 - Aug 16, 2018
-7.54%
Feb 14, 2007 - Apr 16, 2007
#15-12.30%
May 8, 2013 - Oct 16, 2013
-7.37%
Jan 21, 2014 - Feb 13, 2014

Correlation

Correlation between BN and GSK is 0.82 which considered as a strong positive correlation - the stocks tend to move together.

0.82
-101

Dividend Comparison (2000 - 2026)

BN vs GSK dividend yield comparison.

YearBNGSK
20260.33%1.73%
20250.52%3.42%
20240.56%4.60%
20230.70%3.75%
20221.44%5.47%
20211.12%4.99%
20201.55%5.59%
20191.11%4.35%
20181.56%5.65%
20171.29%5.83%
20161.58%6.86%
20151.50%5.93%
20141.36%6.20%
20134.64%4.51%
20121.50%5.70%
20111.89%4.83%
20101.56%5.10%
20092.34%4.39%
20088.87%5.74%
20071.31%4.09%
20061.21%3.29%
20051.17%3.03%
20041.76%3.38%
20033.96%2.77%
20025.61%3.10%
20016.36%1.54%
20004.47%4.57%

Select Stocks to Compare